Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 2 is a human pseudogene in the histone H3 family. Unlike the canonical histone H3 genes, which encode proteins essential for chromatin structure and regulation, H3P2 is considered non-coding and is classified as a pseudogene because it does not produce a functional histone protein[1][3][5][12]. While functional histone H3 variants are actively involved in chromatin regulation and gene expression, pseudogenes like H3P2 can arise from gene duplication or retrotransposition and are typically non-functional remnants within the genome. There is no evidence that H3P2 participates directly in any biological processes, disease mechanisms, or serves as a drug target, biomarker, or safety concern[1][3][5][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 2 (H3P2).